dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada GLP-1-RA inhibitors in the management of type 2 diabetes DPP-4 Inhibitors and the Quest
Description
Recent advancements in GLP-1-based therapies 8.1
Thomas, D
GLP-1 receptor agonists, like semaglutide and tirzepatide, can slow down how quickly your stomach empties
Whilst emerging evidence suggests the extensive therapeutic potential of GLP-1, further studies are needed to fully elucidate its mechanisms and its clinical applications in gastrointestinal disorders
E.HodgsonJ
